Agilon Health faces potential delisting from the New York Stock Exchange due to a significant drop in stock price, which has fallen below one dollar per share for thirty consecutive trading days. The companys third-quarter earnings report revealed a larger financial loss than expected, leading to a seven percent decline in stock price. To regain compliance, Agilon Health plans to pursue a reverse stock split, requiring shareholder approval. The company has been given a six-month window to comply with the exchanges listing rules. Analysts concerns about the companys performance and outlook have contributed to the negative sentiment. Agilon Healths stock has been highly volatile, with a significant drop in value since the start of the year, trading at just sixty-seven cents per share, down over sixty-five percent. Long-term investors have seen their investments plummet, with a thousand-dollar investment now worth only twenty-one dollars and sixty cents.

The Daily News Now! — Every city. Every story. AI-powered.

---

Hosted on Acast. See acast.com/privacy for more information.